The effect of cholecalciferol metabolites on ornithine decarboxylase activity and on DNA synthesis in developing long bones was investigated in vitamin D-depleted rats.
The effects of 24R,25-dihydroxycholecalciferol and of la,25-dihydroxycholecalciferol on ornithine decarboxylase activity and on DNA synthesis in the epiphysis and diaphysis of rat bone and in the duodenum Dalia The effect of cholecalciferol metabolites on ornithine decarboxylase activity and on DNA synthesis in developing long bones was investigated in vitamin D-depleted rats.
In the epiphysis there was a 6.4-fold increase in ornithine decarboxylase activity 5 h after a single injection of 24R,25-dihydroxycholecalciferol but not of 24S,25-dihydroxycholecalciferol or other vitamin D metabolites. In comparison, in the diaphysis and duodenum, la,25-dihydroxycholecalciferol, but not other vitamin D metabolites, caused a 3-3.5-fold increase in the enzyme activity. The enzyme activity in the tissues examined attained a maximal value at 5 h after the injection of the metabolites. The activity of ornithine decarboxylase in the epiphysial region increased dose-dependently as the result of a single injection of 24R,25-dihydroxycholecalciferol and attained a maximal value at a dose between 30 and 3000ng. In addition, administration of 24R,25-dihydroxycholecalciferol, but not 24S,25-dihydroxycholecalciferol or other metabolites, caused within 24h a 1.7-2.0-fold increase in [3Hlthymidine incorporation into DNA of the epiphyses of tibial bones. In comparison, la,25-dihydroxycholecalciferol caused a 1.5-fold increase in [3Hlthymidine incorporation into DNA of the diaphyses and of the duodenum. The present data indicate that 24R,25-dihydroxycholecalciferol is involved in the regulation of epiphyseal growth, whereas 1 a,25,dihydroxycholecalciferol stimulates the proliferation of cells in the diaphysis of long bones and in the intestinal mucosa.
24,25-Dihydroxycholecalciferol, a metabolite of cholecalciferol, is probably involved in the development of embryonic cartilage and in endochondral bone formation (Ornoy et al., 1978; Endo et al., 1980) . The main effect of la,25-(OH)2D3, the biologically active metabolite of vitamin D, on bone is stimulation of bone mineral mobilization (Raisz et al., 1972; Brommage & Neuman, 1979) . The mechanism of action of la,25-(OH)2D3, has been extensively examined in chick and rat intestine (Wasserman et al., 1968; Brumbaugh & Haussler, 1974; Zerwekh et al., 1974; Spencer et al., 1976 (Somjen et al., 1982a,b) . Other studies have shown a specific nuclear uptake of 24,25-(OH)2D3 and its effects on DNA polymerase activity and proteoglycan synthesis in cultured growth-plate chondrocytes (Corvol et al., 1978 (Corvol et al., , 1980 . Ornithine decarboxylase (EC 4.1.1.17) is the rate-limiting enzyme in the biosynthesis of polyamines (Russell & Snyder, 1968; Pegg & WilliamsAshman, 1968) . Ornithine decarboxylase activity is markedly enhanced in growing tissues and is considered to be associated with cell proliferation (Russell & Snyder, 1968; H6ltti & Janne, 1972) . It has been shown that la,25-(OH)2D3 administered to vitamin D-deficient chicks significantly increases the activity of ornithine decarboxylase in the duodenal mucosa (Shinki et al., 1981) (Lawson et al., 1969) , and kept in darkness. At 130 days of age the females were mated with normal male rats and maintained during gestation and lactation on the same vitamin D-deficient diet (Somjen et al., 1982a) . The weanling pups were fed with the same diet for 2 (additional) weeks. Vitamin D deficiency was verified by plasma analysis for 25-(OH)D3 and la,25-(OH)2D3 (Weisman et al., 1977; Eisman et al., 1976) . All animals had no detectable concentrations of 25(OH)D3 (<1.6ng/ml) or la,25(OH)2D3 (<5pg/ml). Then cholecalciferol or its metabolites, in 0.2ml of 20% (v/v) ethanol in propylene glycol, were injected intraperitoneally.
Effects of cholecalciferol and its metabolites on ornithine decarboxylase activity At 5h after the administration of cholecalciferol (10,g), 25(OH)D3 (2.5,ug), 24R,25-(OH)2D3 (300ng), 24S,25-(OH)2D3 (300ng) or la,25-(OH)2D3 (60ng), the animals were killed. The epiphyses and diaphyses of the tibiae, as well as the duodenal mucosa, were quickly removed, washed thoroughly with cold 0.9% NaCl and homogenized in an Ultra-Turrax homogenizer (homogenizing buffer: 10mM-Tris/HCl buffer, pH 7.5, containing 250mM-sucrose, 0.5 mM-dithiothreitol, 0.1 mM-disodium EDTA and 0.1 mM-pyridoxal 5'-phosphate). The homogenate was centrifuged at 380OOg for 10min, and the resulting supernatant was used for the enzyme assay.
We have also examined the time course of change in epiphysial, diaphysial and duodenal ornithine decarboxylase activity at 2, 5, 14 and 24h after the administration of 24R,25-(OH)2D3 (300 ng) or la,25-(OH)2D3 (60ng).
In another experiment we have examined the dose-dependent stimulation of epiphysial ornithine decarboxylase activity at 5h after a single injection of 24R,25-(OH)2D3 (30-3000ng).
Assay ofornithine decarboxylase activity Ornithine decarboxylase activity was measured by a modified version of the method described previously (Kaye et al., 1973; Icekson & Kaye, 1976) . The reaction mixture (final volume 100,l) consisted of an enzyme preparation (0.04-1.Omg of protein), 0.5 mM-DL-[l1-'4Clornithine, 0.05 mM-pyridoxal 5'-phosphate and 5 mM-dithiothreitol in 50mM-Tris/HCl buffer, pH 7.8. Incubation was at 37°C for 60min in 15mmx58mm disposable plastic vials containing a polypropylene centre well suspended from a rubber bottle-stopper, which provided a gastight seal. The 14CO2 released was absorbed in 0.25 ml of the organic base mixture Soluene (Packard Instrument Co.), placed in the centre well, which also contained a folded filter paper to increase the absorptive surface. The incubation was ended by injecting 0.5 ml of 3 M-H2SO4 into the reaction mixture. Then the tubes were incubated for an additional 25 min at 370C to complete the absorption of 14C02. thymidine into acid-insoluble material and the content of DNA were measured as previously described (Somjen et al., 1980; Burton, 1956 calciferol, caused a 3-3.5-fold increase in the enzyme activity in the diaphyses of the tibiae and in the duodenum (Table 1) . Whereas the natural isomer of 24,25-(OH)2D3, namely 24R,25-(OH)2D3, caused a significant increase in ornithine decarboxylase activity in the epiphyses, the synthetic isomer 24S,25-(OH)2D3 had no effect on the enzyme activity. Fig. 1 Fig. 2 shows the dose-dependent enhancement of epiphysial ornithine decarboxylase activity at 5 h after injection of 24R,25-(OH)2D3. The enzyme activity attained a maximum value between 30 and 3000ng of 24,25-(OH)2D3.
Administration of 24R,25-(OH)2D3, but not of la,25-(OH)2D3 (60ng), caused within 24h a 1.7-2-fold increase in [3Hlthymidine incorporation into DNA of the epiphyses of tibiae. In comparison, la,25-(OH)2D3, but not 24R,25-(OH)2D3, caused a 1.5-fold increase in [3Hlthymidine incorporation into DNA of the diaphyses and the duodenum (Table 2) .
In contrast with the results obtained with 24R,25-(OH)2D3, the administration of the synthetic isomer 24S,25-(OH)2D3 had no effect on [3Hlthymidine suggested that 24,25-(OH)2D3 is involved in endochondral bone formation (Ornoy et al., 1978; Endo et al., 1980) . Further studies have demonstrated specific receptors for 24,25-(OH)2D3 in the epiphyses of long bones of vitamin D-depleted rats and in chondrocyte-like cells from chick-embryo limbbud cell cultures (S6mjen et al., 1982a,b) . Other studies have shown a specific nuclear binding of 24,25-(OH)2D3 and its effects on DNA polymerase activity and proteoglycan synthesis in cultured growth-plate chondrocytes (Corvol et al., 1978 (Corvol et al., , 1980 . Little is known, however, about the mode of action of 24,25-(OH)2D3 in its suggested target tissue. Unlike la,25-(OH)2D3, which stimulates both specific mRNA and protein synthesis (Haussler & McCain, 1977) , no specific 24,25-(OH)2D3-induced protein has been demonstrated yet. The present paper shows that 24R,25-(OH)2D3 stimulates both ornithine decarboxylase activity and DNA synthesis in the epiphysial region of the tibia, whereas 1 a,25-(OH)2D3 stimulates the enzyme activity in the diaphyses of long bones. Unlike intestinal calcium-binding protein, which is specifically induced by la,25-(OH)2D3 (Wasserman et al., 1968; Haussler & McCain, 1977) , ornithine decarboxylase cannot be considered as a specific marker for vitamin D activity, since many hormones have been shown to stimulate its activity in their respective target tissues (Cohen et al., 1970; Kaye et al., 1971; Takigawa et al., 1979 (S6mjen etal., 1982a,b) showing the existence of specific receptors for 24R,25-(OH)2D3 in the epiphyses of rat long bones and in chondrocytes from cultures of chickembryo limb-bud cells and of receptors for la,25-(OH)2D3 in the diaphyses of rat long bones.
Accumulating results thus suggest that one of the possible roles of 24,25-(OH)2D3 may be stimulation of cell proliferation and differentiation in the epiphysial growth plate, whereas la,25-(OH)2D3 may have an effect on the proliferation of differentiating bone cells in the diaphyses. It was shown that both metabolites affect Ca2+ transport in primary cultures of bone cells (Eilam et al., 1980) . The possibility that changes in the concentration of Ca2+ ions may influence DNA synthesis in the epiphyses and diaphyses should be considered (Durham & Walton, 1982) . It is known that 24,25-(OH)2D3 is converted into 1,24,25-(OH)2D3 in vitamin D-deficient animals (Holick et al., 1973) , and this could be the final metabolite that acts at the epiphysial cartilage. However, it seems that the hydroxy group at C-24 is necessary for the observed biological action on the epiphysial cartilage, since la,25-(OH)2D3 has no effect on ornithine decarboxylase activity and DNA synthesis in this tissue. 
